University of Oxford

Rounds

• A Alethio TherapeuticsDevelops therapies for myeloproliferative neoplasms, a group of rare blood cancers. $90MSeries A · 5 Nov
• F FluoRokProduces fluorochemicals using a process that avoids hazardous hydrogen fluoride. $29.9MSeries A · 5 Nov
• W Wild BioscienceAI and molecular biology to find useful traits in wild plants for resilient crops $60.4MSeries A · 16 Oct
• P Palmer Energy TechnologyLarge-scale battery energy storage developer, which also acquired Oxford spinout Brill Power $6.7MSeries A · 29 Aug

No round matches these filters.

Often invests with

• Oxford Science Enterprises3
• Barclays Climate Ventures1
• BGF1
• Bidra Innovation Ventures (OCP Group)1
• Braavos Capital1
• Cancer Research Horizons1
• CPI Enterprises1
• Ellison Institute of Technology1